← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS ELIZABETH · Approved 2003-09-12

Drug application

FDA Application #

ANDA075350

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS ELIZABETH

Manufacturer

Actavis Pharma, Inc.

First approval

2003-09-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown